Inc42's 8th D2CX Cohort Spotlights 50 Early-Stage Indian D2C Brands Across Fashion, Beauty & Food

The 12-week accelerator profiles 50 brands spanning jewelry, apparel, beauty, food and home across 11 cities. Standouts include Jagdish Farshan at ₹12 Cr MRR, Roasty Tasty at ₹1.2 Cr and Talk To Crystals at ₹1 Cr, as India's D2C market races toward $310 Bn by 2031 at a 37% CAGR.

— Source publishedSat, 18 Jul, 2026, 17:00 IST·First seen Sat, 18 Jul, 2026, 17:18 IST·Source Inc42 · Buzz

What happened

D2CX by Inc42 · Inc42's 8th D2CX cohort profiles 50 early-stage Indian D2C brands across jewelry, fashion, beauty, food and home, detailing founders, MRR,

Key facts

  • $65 Bn D2C market
  • $310 Bn D2C by 2031
  • 37% CAGR
  • $10 Bn raised since 2015
  • 1,400 funding deals
  • 400+ founders across 8 cohorts
  • 50 brands in cohort
  • 12-week accelerator
  • Jagdish Farshan ₹12 Cr MRR
  • Talk To Crystals ₹1 Cr MRR
  • Roasty Tasty ₹1.2 Cr MRR
  • Sumadhura Foods ₹90 Lakh MRR
  • Varanga ₹75 Lakh MRR

Why this matters

This cohort surfaces 50 pre-scale acquisition and partnership targets across jewelry, apparel, beauty, food, and home in 11 cities—ideal for corporates seeking category tuck-ins ahead of a market projected to nearly 5x by 2031.

What to watch

  • Seed/pre-Series A announcements from named brands (Jagdish Farshan, Roasty Tasty)
  • Blended CAC trends across D2C category as ad inventory tightens ahead of festive season
  • Quick-commerce onboarding of cohort brands (Zepto/Blinkit/Instamart listings)
  • Any consolidation or aggregator (roll-up) interest in sub-₹5Cr MRR brands
  • Revised D2C market CAGR estimates from analysts validating or trimming the 37% figure
  • Track which 3-5 standout brands announce funding rounds within 6 months post-cohort
  • Map cohort brands by category to identify oversupplied verticals (beauty, apparel) vs whitespace (regional food, functional wellness)
  • Watch for quick-commerce distribution partnerships among top cohort revenue performers
  • Monitor Inc42's follow-on data on prior cohort survival/scale rates for base-rate calibration

Also reported by